Purpose To confirm the efficacy of a risk-adapted treatment approach for patients with
clinical stage I seminoma. The aim was to reduce both the risk of relapse and the proportion …

Purpose To assess the efficacy of a risk-adapted treatment policy for patients with stage I
seminoma by using universally accepted risk criteria. Patients and Methods Between 1999 …

Background We aimed to analyze prognostic factors for relapse in stage I seminoma
managed by either active surveillance or adjuvant chemotherapy, and to describe the long …

The treatment options available for the management of stage I seminoma consist of either a
surveillance strategy or adjuvant therapy after orchidectomy. A systematic review was …

Background The purpose of the protocol was to reduce the treatment burden in clinical stage
I (CSI) seminoma by offering risk-adapted treatment. The protocol aimed to prospectively …

Purpose To assess the long-term efficacy and toxicity of front-line cisplatin-based
chemotherapy in patients with stage IIA or IIB testicular seminoma. Patients and Methods …

Background After decades of irradiation as standard therapy for clinical stage I testicular
seminoma, alternative treatment approaches have emerged including postorchiectomy …

Abstract Purpose Clinical stage 1 (CS1) testicular seminoma involves an almost 100%
disease-specific survival in controlled clinical trials. We aimed to find out whether these …

I seminoma will result in approximately 5% of patients who will receive two episodes of
treatment, which may also increase the risk of late complications. The relapse pattern after …

Background Following inguinal orchidectomy, management options for patients with stage I
seminoma include initial surveillance or treatment with adjuvant radiotherapy or …